tiprankstipranks
Advertisement
Advertisement

EDSA Stock Latest News

Edesa Biotech Confirms Mid-2026 Start for Phase 2 Vitiligo Trial of EB06
Company AnnouncementsEdesa Biotech Confirms Mid-2026 Start for Phase 2 Vitiligo Trial of EB06
3d ago
EDSA
Edesa Biotech provides update on EB06 clinical study
PremiumThe Fly
Edesa Biotech provides update on EB06 clinical study
3d ago
EDSA
Edesa Biotech Reports Positive Phase 3 Paridiprubart Results
PremiumCompany Announcements
Edesa Biotech Reports Positive Phase 3 Paridiprubart Results
1M ago
8K
EDSA
Edesa Biotech reports additional results from Phase 3 paridiprubart study
PremiumThe Fly
Edesa Biotech reports additional results from Phase 3 paridiprubart study
1M ago
EDSA
Edesa Biotech reports Q1 EPS (28c), consensus (45c)
PremiumThe Fly
Edesa Biotech reports Q1 EPS (28c), consensus (45c)
1M ago
EDSA
Midday Fly By: Intel eyes SambaNova, Cencora to acquire OneOncology
PremiumThe FlyMidday Fly By: Intel eyes SambaNova, Cencora to acquire OneOncology
3M ago
KO
COR
Edesa Biotech Advances Dermatology and Respiratory Programs in Fiscal 2025
Premium
Company Announcements
Edesa Biotech Advances Dermatology and Respiratory Programs in Fiscal 2025
4M ago
EDSA
EDSA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
EDSA Earnings this Week: How Will it Perform?
4M ago
EDSA
Edesa Biotech to Participate in Key Industry Conferences
PremiumCompany Announcements
Edesa Biotech to Participate in Key Industry Conferences
5M ago
EDSA
Edesa Biotech Announces Positive Phase 3 Study Results
PremiumCompany Announcements
Edesa Biotech Announces Positive Phase 3 Study Results
5M ago
8K
EDSA
Edesa Biotech announces Phase 3 study of paridiprubart met primary endpoint
PremiumThe Fly
Edesa Biotech announces Phase 3 study of paridiprubart met primary endpoint
5M ago
EDSA
Edesa Biotech and InflaRx: Breathing New Life into ARDS Treatment
PremiumCompany Announcements
Edesa Biotech and InflaRx: Breathing New Life into ARDS Treatment
5M ago
EDSA
IFRX
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Bevacizumab
PremiumCompany AnnouncementsEdesa Biotech and InflaRx: Advancing ARDS Treatment with Bevacizumab
5M ago
EDSA
IFRX
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Vilobelimab
Premium
Company Announcements
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Vilobelimab
5M ago
EDSA
IFRX
JUST BREATHE: A New Hope for ARDS Treatment and Market Impact
Premium
Company Announcements
JUST BREATHE: A New Hope for ARDS Treatment and Market Impact
5M ago
EDSA
IFRX
Edesa Biotech Amends Agreement with Canadian Government
PremiumCompany Announcements
Edesa Biotech Amends Agreement with Canadian Government
6M ago
8K
EDSA
Edesa Biotech Launches At-The-Market Offering Program
PremiumCompany Announcements
Edesa Biotech Launches At-The-Market Offering Program
7M ago
8K
EDSA
Edesa Biotech Advances Vitiligo Treatment Amidst Steady Financial Performance
PremiumCompany Announcements
Edesa Biotech Advances Vitiligo Treatment Amidst Steady Financial Performance
8M ago
EDSA
EDSA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
EDSA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8M ago
EDSA
Edesa Biotech files $150M mixed securities shelf
PremiumThe FlyEdesa Biotech files $150M mixed securities shelf
8M ago
EDSA
Edesa Biotech’s ARDS Study: A Breath of Fresh Air for Investors?
Premium
Company Announcements
Edesa Biotech’s ARDS Study: A Breath of Fresh Air for Investors?
9M ago
EDSA
Edesa Biotech Advances ARDS Treatment with JUST BREATHE Study
Premium
Company Announcements
Edesa Biotech Advances ARDS Treatment with JUST BREATHE Study
9M ago
EDSA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >